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Abstract: BACKGROUND/AIMS: To investigate the renal phenotype under conditions of an activated
renal ET-1 system in the status of nitric oxide deficiency, we compared kidney function and morphol-
ogy in wild-type, ET-1 transgenic (ET+/+), endothelial nitric oxide synthase knockout (eNOS-/-) and
ET+/+eNOS-/- mice. METHODS: We assessed blood pressure, parameters of renal morphology, plasma
cystatin C, urinary protein excretion, expression of genes associated with glomerular filtration barrier and
tissue remodeling, and plasma metabolites using metabolomics. RESULTS: eNOS-/- and ET+/+eNOS-
/- mice developed hypertension. Osteopontin, albumin and protein excretion were increased in eNOS-/-
and restored in ET+/+eNOS-/- animals. All genetically modified mice developed renal interstitial fi-
brosis and glomerulosclerosis. Genes involved in tissue remodeling (serpine1, TIMP1, Col1a1, CCL2)
were up-regulated in eNOS-/-, but not in ET+/+eNOS-/- mice. Plasma levels of free carnitine and
acylcarnitines, amino acids, diacyl phosphatidylcholines, lysophosphatidylcholines and hexoses were de-
screased in eNOS-/- and were in the normal range in ET+/+eNOS-/- mice. CONCLUSION: eNOS-/-
mice developed renal dysfunction, which was partially rescued by ET-1 overexpression in eNOS-/- mice.
The metabolomics results suggest that ET-1 overexpression on top of eNOS knockout is associated with
a functional recovery of mitochondria (rescue effect in ￿-oxidation of fatty acids) and an increase in
antioxidative properties (normalization of monounsaturated fatty acids levels).
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Abstract
Background/Aims: To investigate the renal phenotype under conditions of an activated 
UHQDO(7V\VWHPLQWKHVWDWXVRIQLWULFR[LGHGHÀFLHQF\ZHFRPSDUHGNLGQH\IXQFWLRQDQG
morphology in wild-type, ET-1 transgenic (ET+/+), endothelial nitric oxide synthase knockout 
(eNOS-/-) and ET+/+eNOS-/- mice. Methods: We assessed blood pressure, parameters 
of renal morphology, plasma cystatin C, urinary protein excretion, expression of genes 
DVVRFLDWHGZLWKJORPHUXODUÀOWUDWLRQEDUULHUDQGWLVVXHUHPRGHOLQJDQGSODVPDPHWDEROLWHV
using metabolomics. Results: eNOS-/- and ET+/+eNOS-/- mice developed hypertension. 
Osteopontin, albumin and protein excretion were increased in eNOS-/- and restored in 
(7H126 DQLPDOV $OO JHQHWLFDOO\ PRGLÀHG PLFH GHYHORSHG UHQDO LQWHUVWLWLDO ÀEURVLV
and glomerulosclerosis. Genes involved in tissue remodeling (serpine1, TIMP1, Col1a1, CCL2) 
were up-regulated in eNOS-/-, but not in ET+/+eNOS-/- mice. Plasma levels of free carnitine 
and acylcarnitines, amino acids, diacyl phosphatidylcholines, lysophosphatidylcholines and 
hexoses were descreased in eNOS-/- and were in the normal range in ET+/+eNOS-/- mice. 
Conclusion: eNOS-/- mice developed renal dysfunction, which was partially rescued by ET-1 
overexpression in eNOS-/- mice. The metabolomics results suggest that ET-1 overexpression 
on top of eNOS knockout is associated with a functional recovery of mitochondria (rescue 
HIIHFWLQǄR[LGDWLRQRIIDWW\DFLGVDQGDQLQFUHDVHLQDQWLR[LGDWLYHSURSHUWLHVQRUPDOL]DWLRQ
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Introduction 
Endothelin-1 (ET-1) and nitric oxide (NO) closely interact in a manner of a local network, 
i.e. ET-1 stimulates NO production, NO in turn inhibits ET-1 expression proportionally in 
different cell-types [1]. An in vivo example of interaction between ET-1 and NO production 
was demonstrated in transgenic mice overexpressing ET-1 (ET+/+), which have a normal 
blood pressure. The vasoconstrictory effects of ET-1 were antagonized by an increased 
production of NO, the endothelial counterpart of ET-1 in animals overexpressing ET-1 [2]. 
An excessive renal production of ET-1 is often observed in patients with chronic kidney 
disease (CKD) of diabetic and non-diabetic origin [3]. In contrast, in CKD the overall NO 
availability is decreased, in part due to endothelial dysfunction [4]. To date, the only known 
agents to block the activity of ET-1, which have been approved for clinical use, are ET receptor 
antagonists [5], although they have not so far been validated for a therapeutic use in CKD due 
to adverse effects such as water and salt retention [3, 6].  
We have previously generated crossbred animals of ET transgenic mice (ET+/+) 
and endothelial nitric oxide synthase knockout (eNOS-/-) mice to investigate the role of 
ET-1 overproduction in endothelial  function and blood pressure in the conditions of NO 
ϐȏ͹ȐǤǡǦ
/- and ET+/+eNOS-/- mice developed high blood pressure in contrast to  wild-type (WT) and 
ET+/+ mice, which remained normotensive [8]. Interestingly, left ventricular catheterization 
showed that only eNOS-/- mice, but not ET+/+eNOS-/- developed diastolic dysfunction 
[8]. The aim of the present work was to investigate renal phenotypic consequences and 
mechanisms of ET/eNOS interaction using crossbred ET+/+eNOS-/- mice. 
Materials and Methods
Mouse model
Human ET-1 transgenic mice (line 856) [9] and eNOS-/- mice [10] were generated as described 
previously. Only homozygous mice were used for breeding. We ensured the steadiness of the genotype over 
the generations. Crossbred mice were created by breeding female eNOS-/- mice with male ET+/+. Study 
groups were composed as follows: WT, ET+/+, eNOS-/-, and ET+/+eNOS-/- mice. The number of animals 
ͳͶǤǤϐͻǤ






          ȏͻǡ ͳͳȐǤ ϐǡ
ϐǤǦ
to the total area of the picture was analyzed using the program ImageJ (shareware by National Institutes 
ǡǡǡȌǤϐ
acid-Schiff positive area within the glomerulus by a semi-quantitative score system using a score of 1-4 by 
two investigators who were blinded to the study groups. Scores 1, 2, 3, and 4 represented mesangial matrix 
ͲǦʹͷΨǡʹͷǦͷͲΨǡͷͲǦ͹ͷΨǡ͹ͷǦͳͲͲΨǡǤ
Plasma and urinary analyses
Urinary concentrations of albumin, H-FABP, and osteopontin were determined in urine samples 
collected in a six hours time period in metabolic cages. ELISA  assays were conducted to determine the levels 
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protocols provided by the suppliers of the assays. Optical density of the samples was measured at 450 nm 
ȋϐʹͲͲǡ
Ǥ¡ǡȌǤ










separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to a nitrocellulose 
membrane (AmershamTM HybondTM ECL, GE Healthcare, Milwaukee, USA) in transfer buffer (184 mM Glycin, 




Aldrich, Steinheim, Germany) were used. 
ϔǦ
ϐȋǡǡ
Germany) and checked for integrity on a Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). For 
ǡͳɊϐǦȋ
ǡǤ




 ϐ   ȋǡ ǡ
ǡȌȋͳȌ͸Ǧ	ȋ
Ȍ͵ͺͶǦ
well microtiter plates. cDNA samples (20 ng) were run in triplicates in reaction volumes of 20 μl (384-well 
microtiter plates) under standard thermocycler conditions. TaqMan probe sets were generated by using 
Primer3Plus (ǣȀȀǤǤȀǦȀ͹Ȁ͹ȌǤ   
was calculated using the ddCt term (Applied Biosystems, User Bulletin No. 2) related to endogenous controls 
͵ʹȾǦǤ
the following NCBI GenBank accession numbers (Table 1). 

   ϐ      IDQTM p150 kit 
ȋ
ǡǡȌǤ	ǦȀȋ	ǣϐ
injection analysis) [12, 13]. The assay includes free carnitine, 40 acylcarnitines (Cx:y), 14 amino acids (13 
proteinogenic + ornithine), hexoses (sum of hexoses – about 90-95 % glucose), 92 glycerophospholipids 
ȋͳͷȋȌ͹͹ȋȌȌǡͳͷȋǣȌǤ
The abbreviations Cx:y are used to describe the total number of carbons and double bonds of all chains, 
respectively [13]. Mass spectrometric (MS) analyses were done on a API 4000 system (AB Sciex Deutschland 
GmbH, Darmstadt, Germany) equipped with a 1200 Series HPLC (Agilent Technologies Deutschland GmbH, 
Böblingen, Germany) and a HTC PAL auto sampler (CTC Analytics, Zwingen, Switzerland) controlled by the 
ͳǤͶǤͳȋǡ	ǡǡȌǤϐ
of metabolite concentrations as well as quality assessment was performed with the MetIQ™ software, which 
is an integral part of the AbsoluteIDQ™ kit (both from Biocrates Life Sciences AG, Innsbruck, Austria). 
The AbsoluteIDQTM p150 kit has been proven to be in conformance with FDA-Guidline "Guidance 
for Industry - Bioanalytical Method Validation” (May 2001) [14], which implies proof of reproducibility 
within a given error range. The metabolite panel covered by targeted metabolomics approach has been 
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Statistical analysis
All data are expressed as means ± SEM. Statistical analyses were performed using GraphPad Prism 
5 software (La Jolla, CA, USA). For comparison of two parametrically distributed groups of data unpaired 
t-test with equal or unequal variance (Welch’s correction) was applied. For nonparametrically distributed 
   ǦǦ Ǥ    ϐ
when P < 0.05.
Results
Systolic blood pressure 
ϐǦȀǦȋͳ͵͹Ǥ͸ά͵Ǥ͸ǢP < 0.001 versus WT) 
ΪȀΪǦȀǦȋͳʹͻǤͳάͷǤͲǢP < 0.05 versus WT) compared to WT (111.9 ± 4.2 
ȌΪȀΪȋͳͲͻǤ͹ά͹ǤͷȌͻǤ
tendencies were revealed starting as early as 3 months of age (Table 2). SBP in eNOS-/- 
ϐΪȀΪǦȀǦǤ

Plasma cystatin C was elevated in both groups with eNOS genetic ablation (P < 0.05 
versus WT), but not in ET+/+ mice (Fig. 1a). In contrast, albuminuria and proteinuria were 
ϐȋP < 0.01 versus WT) increased only in eNOS-/- compared to WT (15.0- 
͵ǤͳǦǡ	ǤͳǦȌǡϐ
 ϐ     
control. Interestingly, in crossbred mice both albuminuria and proteinuria levels were 
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Urine biomarkers
Urinary excretion of osteopontin was 3.4-fold increased in eNOS-/- mice versus WT 
(P < 0.01) and restored in crossbred mice versus eNOS-/- (P < 0.001, Fig. 2a). Urinary 
excretion of heart muscle-type fatty acid binding protein (H-FABP, measured in ng/24h) was 
͸Ǥ͸ͻΪȀǦͳǤͺͷǢ͵Ǥ͵͸ΪȀǦͳǤ͸ͶΪȀΪǢͳͶǤͻͻΪȀǦ͵ǤͻͳǦȀǦǢ͹ǤͻͳΪȀǦͳǤͷ͸
ΪȀΪǦȀǦǤϐǦ	
the genotypes (Fig. 2b).
Kidney morphology
       ϐ   ΪȀΪ 
ET+/+eNOS-/- versus WT, whereas in the eNOS-/- group it was lower compared to all other 
groups (Table 3). ET+/+, eNOS-/- and ET+/+eNOS-/- mice all developed glomerulosclerosis, 
as assessed by increased deposits of periodic acid Schiff (PAS) positive material within the 
ϐǡϐ
ȋ͵ȌǤϐǡǦǦȋ͵Ȍǡ
 ȋ Ȍ ϐ 
groups. 
ϔǦǦ
The eNOS protein expression was increased in the ET+/+ group (P < 0.01 versus WT). 
ǡǡϐ
in Table 4.
Table 2. Systolic Blood Pressure. Systolic blood pressure in 3 and 9 months old mice, mm Hg. 
Values are given as mean ± SEM. * P δͲǤͲͷǢȗȗP δͲǤͲͳǢȗȗȗP < 0.001 vs WT
Fig. 1. Plasma cystatin C levels (a), urinary albumin (b) and protein (c) daily excretion. Values are given as 
mean ± SEM. * P < 0.05, ** P < 0.01.
Fig. 2. Values are given as mean 
± SEM. * P δ ͲǤͲͷǢ ȗȗ P δ ͲǤͲͳǢ 
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Podocyte-associated genes (podocalyxin-like protein 1, nephrin and integrin alpha 
3 subunit) showed only minor regulation patterns (Fig. 3a-c). In contrast, glomerular 
basement membrane (GBM) – associated genes were differently regulated. In ET+/+ and 
eNOS-/- mice a down-regulation of collagen IV gene expression was observed, whereas 
the gene encoding one of the laminin subunits (Lamc1) was up-regulated. Lamb2, a gene 
responsible for the synthesis of another laminin subunit, showed a trend (P = 0.056 versus 
WT) towards up-regulation in eNOS-/- mice. Crossbred animals showed only a minor 
regulation of GBM associated genes (Fig. 3d-f). Endothelial cells-associated genes CD34 and 
͵ͳϐǦΪȀΪǦȀǦǦȀǦȋ	Ǥ
͵ǦȌǤȋͳǡͳʹȌϐ
up-regulated in eNOS-/- animals compared to WT. Col1a1 gene showed a trend towards up-
ȋαͲǤͲ͹͹ȌǦȀǦǤ
ȋ	ǤͶǦȌǤ ͳǡͳǡʹͳͳ 
in the ET+/+eNOS-/- mice. Interleukin 18 gene expression was up-regulated in ET+/+ mice 
versus all other groups (Fig. 4f). The angiotensin I-converting enzyme 2 (ACE2) gene was 
down-regulated in eNOS-/- animals compared to all other groups (Fig. 4g). 
Plasma metabolites
Free carnitine and acyl carnitines (Fig. 5), diacyl phosphatidylcholines (PCaa), 
ȋȌȋ	Ǥ͸Ȍǡȋ	Ǥ͹Ȍǡȋ	ǤͺȌ
exhibited a similar pattern, in which the metabolites in eNOS-/- or transgenic ET+/+ were 
lower in concentration, whereas these metabolites of crossbred (ET+/+eNOS-/-) animals 
were comparable in concentration to those found in WT animals. We did not observe 
changes in the activity of mitochondrial carnitine palmitoyl transferase I in any of the 
transgenic models, as depicted by a stable CPT-I ratio (calculated from octadecanoylcarnitine 
+ hexadecanoylcarnitine/carnitine free (C18+C16)/C0). The oxidative degradation of even-
Table 3. ǤͻǤ
mean ± SEM. * P δͲǤͲͷǢȗȗȗδͲǤͲͲͳǢȚȚȚ P < 0.001 vs eNOS-/-
Table 4.  ϐ  Ǧͳ  Ǧ-
ǤȋǦȌǡ-
thelin receptor type B (ET-B), endothelial nitric oxide synthase (eNOS) and inducible 
nitric oxide synthase (iNOS) in 9 months old mice. Values are given as mean ± SEM. 
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numbered fatty acids in mitochondria (characterized by carnitine free/acetylcarnitine (C2/
C0) ratio) compared to the overall activity of ß-oxidation (measured by acetylcarnitine + 
propionylcarnitine/carnitine free (C2+C3)/C0) ratio) revealed the aforementioned pattern 
ȋ	Ǥ ͷǦȌǤ ǡ     ȋ   ϐȌǡ
representative of each metabolite class. 
Desaturation of fatty acid chains in the PC(aa) or acyl carnitines abrogated the 
ǡǦȀǦΪȀΪȋ	ǤͷǦǢ	Ǥ͸ǦȌǤǡ
of their saturation level, revealed differences between WT, eNOS-/- and ET+/+ (Fig. 6d-f). 
Fig. 3. ǦȋǦͳȋȌǡȋȌǡ͵-
unit (c)), glomerular basement membrane- (collagen IV alpha 1 (d), laminin beta 2 (e), laminin gamma 1 (f)) 
and endothelial cells- associated genes (cluster of differentiation 34 (g) and cluster of differentiation 31 (h)) 
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Total alkyl-alkyl phosphatidylcholines PCaa showed a rescue effect but total acyl-alkyl-
phosphatidylcholines (PCae) did not (Fig. 6g-i). 
Fig. 4. ǤͳȀ
plasminogen activator inhibitor-1 (a), tissue inhibitor of metalloproteinase 1 (TIMP-1) (b), collagen type I 
alpha 1 (c), connective tissue growth factor (d), chemokine (C-C motif) ligand 2 / monocyte chemoattrac-
tant protein-1 (e), interleukin 18 (f), angiotensin I-converting enzyme 2 (ACE2) (g). Values are given as 
mean ± SEM. * P δͲǤͲͷǢȗȗP δͲǤͲͳǢȗȗȗP < 0.001.
Fig. 5. Plasma levels of free carnitine (a), acetylcarnitine (b), carnitine free/acetylcarnitine ratio (c), ace-
tylcarnitine + propionylcarnitine/carnitine free ratio (d), dodecenoyl-L-carnitines C12 and C12:1 (e and f), 
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Discussion
We compared kidney function and morphology in wild-type mice, ET-1 transgenic 
(ET+/+) mice, endothelial nitric oxide synthase knockout (eNOS-/-) mice, and ET+/+eNOS-/- 
crossbred mice to investigate the renal phenotype under conditions of an activated renal 
Ǧͳ   ϐǤ   ϐ
of eNOS leads to the development of proteinuria, which is improved by overexpression of 
Ǧͳȋ	ǤͳȌǤϐȋ	Ǥ͵Ȍ
that the restoration of the markedly increased protein/albumin excretion in eNOS knockout 
mice might be due to a normalization of gene expression involved in glomerular basement 
Fig. 6. Plasma levels of phosphatidylcholine diacyls C30:0 (a) and C30:2 (b), mono-unsaturated glycero-
phosphocholines (c), lysophosphatidylcholine acyls C18:0 (d), C18:1 (e) and C18:2 (f), total lysophospha-
tidylcholines (g), total diacyl-containing phosphatidylcholines (h) and total acyl-alkyl- containing phospha-
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integrity. Increased urinary osteopontin excretion, (Fig. 2a) as well as renal expression of 
   ϐ ȋͳǡǦͳǡ  ʹȌǡ 
ϐʹȏʹͲȐǦȀǦȋ	ǤͶȌ
by ET-1 overexpression. In order to identify potential mechanisms leading to the restoration 
of the renal phenotype of eNOS-/- mice, we performed metabolomic analyses. These 
analyses indicated that ET-1 overexpression, in addition to an eNOS knockout is associated 
ȋȾǦȌ
increase in antioxidative properties (normalization of monounsaturated fatty acids levels).
Importantly, the phenotype of the ET-1 transgenic mice did not exhibit a measurable 
 ϐ ȋ
	Ȍ ͻǡ   
earlier reports indicating that kidney function in these animals starts to decrease in later 
stages (>12 months) [9]. Protein excretion was only seen in eNOS-/- mice [21–23], but not 
in ET+/+ as reported earlier [9, 24, 25]. ET-1 overexpression on its own does not cause 
proteinuria, but in cases of underlying proteinuric renal diseases, such as pediatric nephrotic 
syndrome or diabetic renal disease, an activated ET-system enhances protein excretion [26]. 
Blood pressure was normal in ET-1+/+ mice, most likely due to an activated NO system 
Fig. 7. Plasma levels of arginine (a), histidine (b), phenylalanine (c), leucine (d), threonine (e), valine (f), 
methionine (g) and tryptophan (h). Values are given as mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001.
Fig. 8. Plasma levels of 
hexoses (a) and sphin-
gomyeline C16:0 (b). 
Values are given as mean 
± SEM. * P < 0.05, ** P < 0.01, 
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ȏʹ͹ȐǤ       ϐ  ΪȀΪǦȀǦ  ǡ 
ǦȀǦȏ͹ȐǤǡǡ
generations of ET+/+eNOS-/- mice, the blood pressure was similar in eNOS-/- mice and 
ET+/+eNOS-/- mice [8, 24, 25]. The reasons why the blood pressure phenotype changes 
slightly over the years is still unknown.




basement membrane (GBM) and endothelial cells. Albumin- and proteinuria can be caused 
by disturbances of any GFB element [28]. In order to better understand the morphology of 

	ǡϐ   Ǥ

lined by a layer of interdigitating podocyte foot processes from the urinary-space side. Our 
Ǧϐ
ϐȀǦȀǦ
seen in ET+/+eNOS-/- mice (Fig. 3).
The GBM itself is composed of extracellular matrix proteins assembled through an 
interweaving of type IV collagen with laminins, nidogen, and sulfated proteoglycans [29]. Any 
changes in the balance of extracellular matrix proteins within GBM may lead to an increased 






WT), while Lamb2 showed a trend towards up-regulation (P = 0.056 versus WT). Similar, 
although less pronounced changes were revealed in ET+/+ mice, whereas in crossbreds 
GBM associated gene expression was similar to WT (Fig. 3d-f). Mutations in genes encoding 
ʹǡͶȽ͵ǡͶȽͶǡͶȽͷ
ȏ͵ͳȐ ϐǤ
proteins, including integrins are known to act as osteopontin receptors [32]. Although their 
interaction in the context of renal dysfunction is not clear yet, it is known that osteopontin is 
ǡϐϐȏ͵͵ȐǤ
osteopontin observed in eNOS-/- (Fig. 2) was consistent with an elevation of SBP (Table 1). 
In addition, we further analyzed renal expression of genes involved in tissue remodeling. In 
agreement with our assumption, increased urinary osteopontin excretion together with an 
up-regulation of osteopontin binding proteins Lamb2 and Lamc1 was accompanied by an up-
ͳǡǦͳǡȋǦȌʹǡ
ȋ	ǤͶȌǤϐǡet al. previously reported 
that decreased NO levels in the kidney aggravated renal dysfunction, damage, hypertrophy, 
ϐǡ  ϐ  
serum creatinine, blood urea nitrogen and urinary protein levels, accompanied by increases 
ϐǡǦȾǡ
inhibitors of metalloproteinases [34]. Therefore, we suggest that the proteinuric phenotype 
in eNOS knockout mice is caused, at least partially, by an impaired GBM composition, which 
is improved in crossbred animals (Fig. 3d-f).
Our current data of an improvement of the functional consequences of a systemic eNOS 

	ϐǦ
/-, but not ET+/+eNOS-/- mice, developed cardiac dysfunction manifested in increased end 
diastolic pressure and time of left ventricular relaxation [8]. Cardioprotective properties of 
ET-1 overexpression on top of eNOS knockout were explained by reduction of cardiac oxidative 
    ȏͺȐǤ ǡ  ϐ   ϐ   
ȏ͵ͷȂ͵͹ȐǤ	ǡ
et al. reported that in patients with CKD plasma ET-1 levels positively correlated with left 
ventricular hypertrophy [35]. The opposite effects of ET-1 overproduction in two different 
settings might be explained by a big heterogeneity within the patient cohort (concomitant 
chronic diseases, age, race etc. are the factors affecting organ function independently of ET-1 
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ǤǤ
antagonist T-0115 ameliorated glomerulosclerosis, the rise in SBP, and prevented left 
ventricular hypertrophy in rats with G-nitro-l-arginine methyl ester (L-NAME) induced 
inhibition of NO synthesis [36]. The differences in the results might be explained by the fact 
ϐΪȀΪǦȀǦǦǡ
study by Nakamura et al. NO production was blocked only for a given time frame. In addition, 
ǦǦϐǤ
Moreover, L-NAME may also have blocked the other isoforms of NOS, which was not the case 
in our model. In the present study, we observed a reduction of urinary protein excretion by 
ET-1 overexpression on top of eNOS-/- genotype. This is somewhat in contradiction with 
ȏ͵ǡ͸ǡʹ ͸Ȑǡ
 Ǥǡ     
were shown to have much more pronounced renoprotective effect than nonselective ones. 
ǡ
excretion, SBP, or kidney morphology parameters in uremic rats with 5/6 nephrectomy [38]. 
The aforementioned effects of ET antagonists were investigated in CKD models such as 5/6 
nephrectomy or diabetic nephropathy, however the pathophysological conditions induced 
in these models are different in comparison to the model used in our study, in which ET-1 
overexpression was not combined with any other insult to the kidney.
The kidney is very active in carnitine metabolism and releases the metabolites into the 
plasma and urine [39]. The metabolic pattern observed in the ET+/+eNOS-/- animals suggests 
a functional recovery of mitochondria. This effect is prominent for internal mitochondrial 
enzymes but not for the carnitine shuttle (CPT-I, EC 2.3.1.21) [40]. Furthermore, the 
same rescue effect is seen in oxidation of even-numbered fatty acids and overall activity 
ȾǦǤǦͳ
ȏͶͳȐϐ
 Ǥ     Ǧ  ϐ  
oxidative damage in the renal cortex of hypertensive rats [42]. It results in an up-regulation 
of both antioxidant enzymes and eNOS [43]. Desaturation of fatty acid chains in the PC(aa) 
or carnitines abrogates the differences observed between WT, eNOS -/- and ET +/+, which 
is in agreement with the observation that saturated fatty acids (e.g. palmitic acids) activate 
ȏͶͶȐǤϐ
and the underlying mechanisms were reported. In erythrocyte membrane lipid composition 
monounstaturated fatty acids (MUFA) are increased in non-diabetic patients with continuous 




activity [49]. Lysophosphatidylcholines (LPCs) are more sensitive to desaturation changes 
as they are composed of only one hydrocarbon chain instead of two present in the PCaas and 
PCaes. Peroxisomal metabolism of phosphatidylcholines is not affected in any of the models 
(neither single nor double mutants) included in our study as the levels of PC(ae)s were not 
affected [50].
Similarly to concentrations of carnitines and lipids, the amino acid levels are normalized 
in ET+/+eNOS-/- animals. This is of interest as these metabolites are biomarkers of complex 
diseases like diabetes type 2 and CKD. Arginine is a known precursor of NO [51] and induces 
oxidative stress through a modulation of NOS activity. Short-term exposure causes an 
increase, and long term exposure a decrease of NOS activity in human endothelial cells [52]. 
ǡϐȋͷȌǡ
tiglylcarnitine (C5:1) and glutaconylcarnitine (C5:1-DC) [53, 54]. The C5:1 is listed within a 
panel of biomarkers patented for the diagnosis of kidney disease [55]. Branched chain amino 
acids (BCAA, leucine, isoleucine and valine) constitute 40% of all amino acids from daily 





























   
   




















Cell Physiol Biochem 2015;37:1474-1490
DOI: 10.1159/000438516
Published online: October 29, 2015 1486
Tsuprykov et al: ET+/+eNOS-/- Genotype is Renoprotective
Cellular Physiology 
and Biochemistry
© 2015 The Author(s). Published by S. Karger AG, Basel
www.karger.com/cpb
ϐȏͷͻȐǤ
patients with CKD showed a decrease in BCAA which might as well be caused by malnutrition 
[60]. Metabolic exchange of BCAA between different tissues was observed to modulate BCAA 
metabolism in CKD [61]. BCAA can enter energy generation in tricarboxylic acid cycle (TCA) 
through the action of branched-chain alpha-keto acid dehydrogenase complex [62]. Branched 

ȏ͸͵ȐǤ
translation via elF4E [64]. eNOS was shown to support both mitochondrial biogenesis and 
metabolic activity [65]. The restoration effects seen in ET+/+eNOS-/- animals in our study 
	ɈǡʹǡǦͳȏͶ͵ǡ͸ͷȐǤ
interpretation of the processes is summarized in Fig. 9 and is based on published and our 
own records. 
Ǥϐ
with CKD and heart failure. We have demonstrated that the functional consequences of a lack 
ǡ
	ǡ
by overexpression of ET-1. We suggest that this might be due to a functional recovery of 
 ȋ   ȾǦ   Ȍ    
properties (normalization of monounsaturated fatty acids levels). The current study is 
in agreement with a previous report showing that eNOS knockout mice develop diastolic 
Fig. 9. Hypothesis: ET-1 overexpression on top of eNOS knockout may cause functional recovery of mi-
tochondria in ET+/+eNOS-/- crossbred mice. ET-1 overexpression on top of eNOS knockout is associated 
ȋȾǦȌ-
xidative properties (normalization of monounsaturated fatty acids levels) possibly due to NFNB, Nrf2, and 
ǦǦͳǤǤ
enzymes are given in orange rounded rectangles. Abbreviations: BCKDC - branched-chain alpha-keto acid 
dehydrogenase complex, PEMT - phosphatidyl ethanolamine methyltransferase, eNOS- endothelial nitric 
ǡȂǡǦǡ
PCae- phosphatidylcholine acylalkyl-chains, PCaa - phosphatidylcholine acylacyl-chains, TCA- tricarboxylic 
acid cycle, ET-1 – endothelin 1, Nrf2 - nuclear factor (erythroid-derived 2)-like 2, elF4E - eukaryotic trans-
   Ͷǡ 	 Ǧ   ǦǦǦ    ǡ
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dysfunction which could be restored by ET-1 overexpression in the heart. This study 
Ǧͳϐ
the regulation of cardiac proteins playing a role in oxidative stress, myocyte contractility, 
and energy metabolism [8].  Thus, besides the fact that blockade of both the ETA and ETB 
receptors may lead to water and salt retention [3, 5, 6], our current data further challenges 
the idea to block the endothelin system in patients with endothelial dysfunction, as it is 
present in CKD due to diabetic nephropathy. 
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